Method of treating proliferative diseases using Eg5 inhibitors
OwnerSpencer David Kimball, Louis J. Lombardo +3inventors
InventorsSpencer David Kimball, Louis J. Lombardo, David B. Rawlins, Hai-Yun Xiao, Deborah L. Roussell
Life of this patent
Estimating the term…
Abstract
The invention provides a method for treating a condition via modulation of the Eg5 protein activity comprising administering to a mammalian species in need of such treatment an effective amount of at least one small molecule Eg5 protein inhibitor. The invention also provides a method for treating a condition via modulation of the Eg5 protein activity comprising administering to a mammalian species in need of such treatment an effective amount of at least one small molecule Eg5 protein inhibitor in combination with at least one other anti-cancer agent.
Claims12
A method for treating a condition via modulation of Eg5 protein activity comprising administering to a mammalian species in need of such treatment an effective amount of at least one small molecule Eg5 protein inhibitor.
Dependencies are inferred from the claim text.